
Building a Preventative Empire: Scaling HRT, Weight Loss, and Vein Health
In this episode, host Don Adeesha welcomes Dr. Charles Mok to discuss the quiet crisis that lies behind all injectable-only practices: commoditization within a rapidly expanding but under-demanding cosmetic industry. According to Dr. Mok, practices designed for longevity are using their cosmetic treatments as the gateway for accessing the entire health timeline of the patient.
This discussion unpacks the process by which one can combine female hormone therapy, GLP weight-loss protocol cycling, and vein health services with their current aesthetics practice, without any external marketing expenses, brand dilution – and with injectable services being the trigger to achieving unparalleled levels of patient retention.
Lastly, Dr. Mok issues a stern warning to injectable-only practitioners about the 22% growth in med spa supply that is currently outpacing demand in the filler market and why aesthetic practices are perfectly suited to lead the longevity space due to the unique position they have always had with respect to their cash-only patients.
Otros episodios de "Business of Aesthetics Podcast Show"



No te pierdas ningún episodio de “Business of Aesthetics Podcast Show”. Síguelo en la aplicación gratuita de GetPodcast.








